Clinical Trials Directory

Trials / Unknown

UnknownNCT06039553

Study of Pulmonary Artery Banding for the Improvement of Left Ventricular Function in Pediatric Heart Failure

A Comprehensive Research of Pediatric Heart Failure -- A Self-control Study of Pulmonary Artery Banding for the Improvement of Left Ventricular Function in Pediatric Heart Failure

Status
Unknown
Phase
Study type
Observational
Enrollment
25 (estimated)
Sponsor
China National Center for Cardiovascular Diseases · Other Government
Sex
All
Age
14 Years
Healthy volunteers

Summary

The goal of this observational study is to learn about the safety and effectiveness of pulmonary artery banding(PAB) therapy in pediatric heart failure(PHF) patients. The main questions it aims to answer are: * Can PAB therapy improve left ventricular(LV) function in PHF patients especially refractory PHF. * Can the complications caused by the PAB therapy be clinically acceptable? Participants underwent PAB therapy will be required to underwent echocardiography, electrocardiograms, complete blood counts, biochemical tests, and measurements of N-terminal pro-brain natriuretic peptide (NT-proBNP) follow-up before the initiation of PAB and at 1 month, 3 months, and 6 months after PAB surgery. Researchers will compare the LV function 6 months after PAB suergey and the preoperative ones to see if there is improvement.

Conditions

Interventions

TypeNameDescription
PROCEDUREpulmonary artery bandingPatient in this group will undergo pulmonary artery banding surgery for congenital heart disease.

Timeline

Start date
2022-01-01
Primary completion
2024-09-01
Completion
2024-12-31
First posted
2023-09-15
Last updated
2023-09-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06039553. Inclusion in this directory is not an endorsement.